|1.||Cao, Bin: 2 articles (05/2014 - 11/2012)|
|2.||Cheng, Gang: 2 articles (05/2014 - 11/2012)|
|3.||Tang, Qiong: 2 articles (05/2014 - 11/2012)|
|4.||Kasper, F Kurtis: 2 articles (10/2012 - 06/2011)|
|5.||Mountziaris, Paschalia M: 2 articles (10/2012 - 06/2011)|
|6.||Mikos, Antonios G: 2 articles (10/2012 - 06/2011)|
|7.||Sing, David C: 2 articles (10/2012 - 06/2011)|
|8.||Tzouanas, Stephanie N: 2 articles (10/2012 - 06/2011)|
|9.||Dorr, Robert T: 2 articles (07/2010 - 01/2002)|
|10.||Ashraf, MohammadJavad: 1 article (10/2015)|
|1.||Breast Neoplasms (Breast Cancer)
03/01/2007 - "They induced high gene expression efficiency in various cell lines, which was significantly greater than poly(ethylenimine) (PEI) especially in 4T1 mouse and MDA-MB-231 human breast cancer cell lines, but they were less cytotoxic. "
05/01/1987 - "The estrogenic and antiestrogenic activity of these aziridine derivatives was investigated in MCF-7 human breast cancer cells. "
11/20/2012 - "The gene expression, cytotoxicity, and cellular uptake mediated by this vector were evaluated against MCF-7 human breast cancer cells (LHRH-receptor-positive) and SKOV-3 human ovarian carcinoma cells (LHRH-receptor-negative) and compared to a peptide vector (K(12)H(6)V(8)) (KHV) without the LHRH ligand and poly(ethylenimine) (PEI). "
10/01/1981 - "Two analogs of the antiestrogen tamoxifen, which bear a chemically reactive aziridine function in place of the dimethylamino group, bind to the estrogen receptor from rat uterus and from MCF-7 human breast cancer cells and appear to react irreversibly with the receptor at the estrogen binding site, in a time-and concentration-dependent fashion. "
11/01/2013 - "Compared with commonly used pDNA polyplexes with poly(ethyleneimine), CP-pDNA nanoparticles induced significantly lower cytotoxicity and less inflammation reaction after implantation into animals. "
10/01/2012 - "We investigated the in vivo therapeutic efficacy of an intra-articular controlled release system consisting of biodegradable poly(dl-lactic-co-glycolic acid) (PLGA) microparticles (MPs) encapsulating anti-inflammatory small interfering RNA (siRNA), together with branched poly(ethylenimine) (PEI) as a transfecting agent, in a rat model of painful temporomandibular joint (TMJ) inflammation. "
06/01/2011 - "As the next step in the development of an intra-articular controlled release system to treat painful temporomandibular joint (TMJ) inflammation, we developed several biodegradable poly(DL-lactic-co-glycolic acid) (PLGA)-based microparticle (MP) formulations encapsulating a model anti-inflammatory small interfering RNA (siRNA) together with branched poly(ethylenimine) (PEI) as a transfecting agent. "
01/01/1967 - "[On the anti-tumor action of N,N'-malonyl-bis-ethyleneimine]."
07/01/1960 - "[Comparative investigation of the action of preparations from the chloroethylamine and ethylenimine groups on experimental homo- and heterotransplanted tumors]."
01/01/1959 - "[On the problem of anti-tumor activity of ethyleneimine derivatives]."
04/01/1950 - "RETARDATION of tumor growth in mice by oral administration of ethylenimine derivatives."
01/01/2015 - "In this study, we have conjugated FA to a chitosan-poly(ethylenimine) copolymer, and have confirmed the low cytotoxicity of the product (namely "CP1.3K-FA") in cancer cells. "
12/01/1975 - "Histological studies showed that the injection of ethyleneimine caused immediate papillary necrosis, followed later by secondary cortical involvement. "
08/01/1982 - "When the concentrating power of the renal medulla is impaired by a single dose of ethylenimine, insufficient to cause necrosis of the whole papilla, further doses of ethylenimine do not cause progressive damage to the papilla."
08/01/1982 - "The severity of the renal papillary necrosis produced in rats by ethylenimine is dependent both on dose and urinary concentration within the medulla. "
08/01/1982 - "Factors influencing the severity and progress of ethylenimine-induced papillary necrosis."
12/12/1978 - "Acute renal papillary necrosis was produced in rats by the administration of ethyleneimine. "
02/01/2013 - "In the present study we developed and evaluated an ethyleneimine binary inactivated isolate from the native BoHV-1 strain (Córdoba-2) in a rabbit model of vaccination and infection. "
12/01/2004 - "Thus, the molecular docking approach resulting in the inhibitory capacity of N-(2-aminoethyl)-1 aziridine-ethanamine provides an attractive small molecule lead compound on which the development of more effective therapeutic agents could be developed to modulate hypertension and for controlling SARS infections."
01/01/2012 - "To develop the diagnostic tests for SVV infection, 5 monoclonal antibodies (mAbs) were produced from mice immunized with binary ethylenimine (BEI)-inactivated SVV. "
|1.||Small Interfering RNA (siRNA)
|3.||polylactic acid-polyglycolic acid copolymer (PLGA)
|4.||glycolic acid (glycolate)
|5.||Ethylene Glycol (Monoethylene Glycol)
|6.||Folic Acid (Vitamin M)
|2.||Investigational Therapies (Experimental Therapy)
|3.||Heterologous Transplantation (Xenotransplantation)